PCM
AEON icon

Pinz Capital Management’s AEON Biopharma AEON Stock Holding History

Pinz Capital Management’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$140K Hold
197
– – 0.25% 86
2022
Q2 		$139K Buy
+197
New +$139K 0.1% 194
2022
Q1 		– Sell
-197
Closed -$138K – 131
2021
Q4 		$138K Buy
+197
New +$139K 0.05% 244

Other funds holding AEON

ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Pinz Capital Management's AEON Position: Q3 2022 in Review

Pinz Capital Management held its AEON Biopharma (AEON) position steady in Q3 2022 at 197 shares worth $140K. The position accounts for 0.25% of the portfolio, ranked #86.

Pinz Capital Management first reported a position in AEON in Q4 2021 and has held it in 3 quarters since. 81 funds tracked by Wall St. Rank hold AEON as of Q3 2022.

  • Pinz Capital Management held 197 shares of AEON Biopharma worth $140K as of Q3 2022.
  • Pinz Capital Management left its AEON Biopharma share count unchanged in Q3 2022.
  • AEON Biopharma made up 0.25% of Pinz Capital Management's portfolio in Q3 2022, its #86 holding.
  • Pinz Capital Management first reported a position in AEON Biopharma in Q4 2021 and has held it in 3 quarters since.
  • 81 funds tracked by Wall St. Rank held AEON Biopharma as of Q3 2022.

Based on Pinz Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.